News

Find News

Filter articles

Showing 1 to 10 of 2840 results

Genentech in $1.7bn immuno-oncology deal

UK, US27-02-2020Sarah Morgan

California-headquartered biotech Genentech has agreed to pay $30 million upfront to develop immuno-oncology therapies with UK-based Bicycle Therapeutics.

Vir Biotech partners with WuXi on COVID-19 antibody treatment

China, Hong Kong, US27-02-2020Sarah Morgan

Immunology-focused Vir Biotechnology and Hong Kong-based WuXi Biologics have become the latest companies to turn their focus to developing treatments for the novel coronavirus.

China approves three Gilead remdesivir patents for COVID-19 treatment

Asia27-02-2020Edward Pearcey

US-based Gilead Sciences has been granted three Chinese patents connected to possible COVID-19 treatment remdesivir, reported He Zhimin, the deputy director of China’s National Intellectual Property Administration.

Sanofi to create ‘world’s second biggest’ API manufacturer

EU27-02-2020Rory O'Neill

French drugmaker Sanofi is looking to create a new European manufacturer of active pharmaceutical ingredients, amid concerns over dependence on a Chinese manufacturing sector hit by coronavirus.

California pay-for-delay ban upheld during appeal, rules Ninth Circuit

US25-02-2020Rory O'Neill

The US Court of Appeals for the Ninth Circuit has blocked generics makers’ request to halt California’s ban on pay-for-delay deals while they challenge the legislation.

GSK and Chinese biotech unite for coronavirus vaccine development

China, UK25-02-2020Sarah Morgan

British drugmaker GSK and Chinese biotech Clover Biopharmaceuticals have partnered to develop a protein-based coronavirus vaccine candidate.

Norton Rose Fulbright promotes US IP head to senior operations role

US24-02-2020Tom Phillips

Norton Rose Fulbright has named Gina Shishima as its new US chief operations partner.

Gilead fails to have US government patents invalidated

US21-02-2020Rory O'Neill

Gilead Sciences has failed in its efforts to have US government patents covering the use of HIV drugs as pre-exposure prophylaxis invalidated.

Illumina asks court to halt BGI’s sequencer distribution

US21-02-2020Sarah Morgan

Genetic sequencing company Illumina is seeking a preliminary injunction to stop its China-based rival BGI from distributing DNA sequencers in the US.

Irish nutrition group faces Kaneka patent suit

US20-02-2020Rory O'Neill

Japanese drugmaker Kaneka has accused Irish nutrition company Glanbia of infringing two patents with its ActiQuinol antioxidant products.

Showing 1 to 10 of 2840 results

LSIPR